Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Involvement of Nitrergic System in Anticonvulsant Effect of Zolpidem in Lithium-Pilocarpine Induced Status Epilepticus: Evaluation of Inos and Cox-2 Genes Expression Publisher Pubmed



Eslami SM1, 2 ; Ghasemi M1, 2 ; Bahremand T2 ; Momeny M3 ; Gholami M1 ; Sharifzadeh M1 ; Dehpour AR2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences, Faculty of Pharmacy, Pharmacology and Toxicology, Tehran, Iran
  2. 2. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Hematology/Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Pharmacology Published:2017


Abstract

This study aims to investigate the role of zolpidem in lithium-pilocarpine induced status epilepticus (SE) and probable mechanisms involved in seizure threshold alteration. In the present study, lithium chloride (127 mg/kg) was administered 20 h prior to pilocarpine (60 mg/kg) to induce SE in adult male Wistar rats. Different doses of zolpidem (0.1, 1, 2, 5, 10 mg/kg) were injected 30 min before pilocarpine administration. Furthermore, to find out whether nitric oxide (NO) plays a role in the observed effect, L-arginine and L-NAME were injected 15 min before zolpidem. Afterward, we identified the particular NO isoform mediating the effect of zolpidem by injecting aminoguanidine (AG) and 7-Nitroindazole (7-NI) 15 min prior to zolpidem. Moreover, in both 6 and 24 h after pilocarpine injection, experimental groups underwent hippocampectomy to evaluate cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) genes expression by quantitative reverse transcription-PCR (qRT-PCR). Pre-treatment with zolpidem significantly prevented the onset of SE in a dose-dependent manner. AG and L-NAME significantly potentiated the anticonvulsant effect of zolpidem while L-arginine inverted this effect. Our qRT-PCR exerted that there was a continuous elevation of iNOS and COX-2 genes expression over 6 and 24 h after pilocarpine administration in SE and L-arginine+Zolpidem groups while in AG/L-NAME+Zolpidem and zolpidem groups this upregulation was prevented. Our study indicates that zolpidem prevents the onset of SE through inhibition of iNOS/COX-2 genes upregulation following lithium-pilocarpine administration. Consistent with our results, we suggest that iNOS activation could be probably upstream of COX-2 gene expression. © 2017 Elsevier B.V.
Experts (# of related papers)